皮肤疾病的非劣质随机对照试验报告质量:一项超流行病学研究
Kevin S Kim1, Brendan Tao2, Hargun Kaur3
1Department of Health Research Methodology, Evidence, and Impact, McMaster University, Hamilton, Canada; Population Health Research Institute, Hamilton, Canada.
The Journal of investigative dermatology
|July 3, 2025
概括
皮肤疾病的非劣势随机对照试验 (NI-RCTs) 的报告质量不一致. 许多研究缺乏关键细节,阻碍了临床实践的整合和治疗疗效的评估.
科学领域:
- 皮肤病学 皮肤病学
- 临床试验方法论 临床试验方法论
- 基于证据的医学 基于证据的医学
背景情况:
- 非劣势随机对照试验 (NI-RCT) 对于将新疗法与既有疗法进行比较至关重要.
- 评估皮肤病学NI-RCT的报告质量对于可靠的临床决策至关重要.
研究的目的:
- 评估NI-RCT关于皮肤疾病的报告质量.
- 识别特定于非劣势性试验设计和执行的报告中的缺陷.
主要方法:
- 系统地搜索MEDLINE和Embase数据库,直到2024年4月.
- 包括在顶级期刊 (h5-指数) 中发表的NI-RCT.
- 使用对NI-RCTs的综合报告试验标准扩展进行评估,并进行独立的重复审查.
主要成果:
- 分析了71个NI-RCT,报告了平均78%的整体和67%的NI-RCT特定项目.
- 只有51.6%的人报告了非劣势假设;36.6%的人证明了非劣势差额.
- 作者和审稿人结论之间的差异发生在24.0%的研究中,原因是报告不足.
结论:
- 对皮肤病的NI-RCT的报告不足以达到最佳水平.
- 关于非劣质标准和分析的关键信息经常被遗漏.
- 为了适当的临床应用NI-RCT发现,需要加强报告标准.
更多相关视频
相关概念视频
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
180
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
180
Clinical Trials
8.6K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
8.6K
Changes in Skin Color: Clinical Perspectives
2.2K
The first thing a clinician sees is the skin, so the examination of the skin should be part of any thorough physical examination. Most skin disorders are relatively benign, but a few, including melanomas, can be fatal if untreated. A couple of the more noticeable disorders, albinism and vitiligo, affect the appearance of the skin and its accessory organs.
Albinism
Albinism is a genetic disorder that affects (completely or partially) the coloring of skin, hair, and eyes. The defect is primarily...
Albinism
Albinism is a genetic disorder that affects (completely or partially) the coloring of skin, hair, and eyes. The defect is primarily...
2.2K
Blinding
2.7K
Blinding is a commonly used method of not telling participants which treatment a subject is receiving. Blinding is a critical part of a randomized control trial or RCT. It reduces the bias that affects the results. In an RCT, blinding is used in the form of a placebo. A placebo effect occurs when untreated subjects falsely believe they have received the treatment and report improved symptoms. A placebo or a dummy treatment is administered to subjects to negate the bias caused by such an effect.
2.7K
Skin Cancer
4.6K
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
4.6K
Skin Diseases and Disorders
4.2K
Skin is the first line of defense and encounters a variety of microbes. Some pathogenic strains are often the cause of a broad range of infections of the skin and other body systems. These conditions can affect people of all ages and may have different causes, including genetic factors, infections, autoimmune reactions, environmental factors, and lifestyle choices.
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
4.2K


